Importantly, the average percent recovery (RC%) was 99.02%, proving the existing optical photoluminescence biosensor is sensitive enough to detect prostate-specific antigen as an important cancer biomarker diagnostic for the prostate with pinpoint precision at very low concentrations. The gene discussed is KLK3; the disease is cancer.